Orange Book product · Brand (NDA)
PREZISTA
DARUNAVIR
At a glance
Dec 18, 2008
Approved
Brand (NDA)
Application
AB
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 18, 2008
17 yr 9 mo ago
Today
Patent 7700645 expires
Listed drug substance patent expiration.
Dec 26, 2026
in 6 mo
Patent 7700645*PED expires
Listed listed patent expiration.
Jun 26, 2027
in 1 yr
Pharmaceutical detail
Active ingredient
DARUNAVIR
Strength
75MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 021976
Product number
004
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2011PREZISTABrand (NDA)
NDA 202895 · JANSSEN PRODS
- 2025DARUNAVIRGeneric (ANDA)
ANDA 202136 · MYLAN
- 2025DARUNAVIRGeneric (ANDA)
ANDA 216168 · ANNORA PHARMA
- 2023DARUNAVIRGeneric (ANDA)
ANDA 214085 · ZYDUS LIFESCIENCES
- 2023DARUNAVIRGeneric (ANDA)
ANDA 212493 · AMNEAL
- 2023DARUNAVIRGeneric (ANDA)
ANDA 210677 · AUROBINDO PHARMA LTD
- 2023DARUNAVIRGeneric (ANDA)
ANDA 206288 · CIPLA
- 2023DARUNAVIRGeneric (ANDA)
ANDA 211578 · DR REDDYS
- 2023DARUNAVIRGeneric (ANDA)
ANDA 215389 · MSN
- 2023DARUNAVIRGeneric (ANDA)
ANDA 202083 · HETERO LABS LTD III
- 2022DARUNAVIRGeneric (ANDA)
ANDA 202073 · LUPIN
- 2017DARUNAVIRGeneric (ANDA)
ANDA 202118 · TEVA PHARMS USA
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7700645 | Dec 26, 2026 | in 6 mo | SubstanceProduct |
| 7700645*PED | Jun 26, 2027 | in 1 yr |

